179 related articles for article (PubMed ID: 16731619)
1. Butyrylcholinesterase attenuates amyloid fibril formation in vitro.
Diamant S; Podoly E; Friedler A; Ligumsky H; Livnah O; Soreq H
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8628-33. PubMed ID: 16731619
[TBL] [Abstract][Full Text] [Related]
2. The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers.
Cottingham MG; Voskuil JL; Vaux DJ
Biochemistry; 2003 Sep; 42(36):10863-73. PubMed ID: 12962511
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro.
Podoly E; Bruck T; Diamant S; Melamed-Book N; Weiss A; Huang Y; Livnah O; Langermann S; Wilgus H; Soreq H
Neurodegener Dis; 2008; 5(3-4):232-6. PubMed ID: 18322399
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
5. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
[TBL] [Abstract][Full Text] [Related]
7. Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase.
Liang D; Blouet JP; Borrega F; Bon S; Massoulié J
FEBS J; 2009 Jan; 276(1):94-108. PubMed ID: 19019080
[TBL] [Abstract][Full Text] [Related]
8. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases.
Alptüzün V; Prinz M; Hörr V; Scheiber J; Radacki K; Fallarero A; Vuorela P; Engels B; Braunschweig H; Erciyas E; Holzgrabe U
Bioorg Med Chem; 2010 Mar; 18(5):2049-59. PubMed ID: 20149667
[TBL] [Abstract][Full Text] [Related]
9. A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation.
De Ferrari GV; Canales MA; Shin I; Weiner LM; Silman I; Inestrosa NC
Biochemistry; 2001 Sep; 40(35):10447-57. PubMed ID: 11523986
[TBL] [Abstract][Full Text] [Related]
10. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier.
Prinz M; Parlar S; Bayraktar G; Alptüzün V; Erciyas E; Fallarero A; Karlsson D; Vuorela P; Burek M; Förster C; Turunc E; Armagan G; Yalcin A; Schiller C; Leuner K; Krug M; Sotriffer CA; Holzgrabe U
Eur J Pharm Sci; 2013 Jul; 49(4):603-13. PubMed ID: 23643737
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
12. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation.
Karlsson D; Fallarero A; Brunhofer G; Guzik P; Prinz M; Holzgrabe U; Erker T; Vuorela P
Eur J Pharm Sci; 2012 Jan; 45(1-2):169-83. PubMed ID: 22108346
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure.
Valle-Delgado JJ; Alfonso-Prieto M; de Groot NS; Ventura S; Samitier J; Rovira C; Fernàndez-Busquets X
FASEB J; 2010 Nov; 24(11):4250-61. PubMed ID: 20585030
[TBL] [Abstract][Full Text] [Related]
16. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.
Podoly E; Shalev DE; Shenhar-Tsarfaty S; Bennett ER; Ben Assayag E; Wilgus H; Livnah O; Soreq H
J Biol Chem; 2009 Jun; 284(25):17170-17179. PubMed ID: 19383604
[TBL] [Abstract][Full Text] [Related]
17. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro.
Jasiecki J; Targońska M; Janaszak-Jasiecka A; Kalinowski L; Waleron K; Wasąg B
Chem Biol Interact; 2023 Dec; 386():110783. PubMed ID: 37884182
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
20. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.
Schlenzig D; Manhart S; Cinar Y; Kleinschmidt M; Hause G; Willbold D; Funke SA; Schilling S; Demuth HU
Biochemistry; 2009 Jul; 48(29):7072-8. PubMed ID: 19518051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
